GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Revenue

argenx SE (argenx SE) Revenue : $1,226 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is argenx SE Revenue?

argenx SE's revenue for the three months ended in Dec. 2023 was $407 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1,226 Mil. argenx SE's Revenue per Share for the three months ended in Dec. 2023 was $6.88. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $21.34.

During the past 12 months, the average Revenue per Share Growth Rate of argenx SE was 175.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 197.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 96.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 48.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, argenx SE's highest 3-Year average Revenue per Share Growth Rate was 197.50% per year. The lowest was -20.70% per year. And the median was 58.85% per year.


argenx SE Revenue Historical Data

The historical data trend for argenx SE's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Revenue Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.46 41.24 497.28 410.75 1,226.32

argenx SE Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 174.16 219.14 270.55 329.79 406.84

Competitive Comparison of argenx SE's Revenue

For the Biotechnology subindustry, argenx SE's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Revenue distribution charts can be found below:

* The bar in red indicates where argenx SE's Revenue falls into.



argenx SE Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,226 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


argenx SE  (NAS:ARGX) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


argenx SE Revenue Related Terms

Thank you for viewing the detailed overview of argenx SE's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE (argenx SE) Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.